Kidney Failure News and Research

RSS

New treatment option for bad breath

More than 90 million Americans can sigh comfortably because of new relief for their bad breath. Dental experts today revealed research highlighting a new treatment option that can eliminate halitosis or chronic bad breath at the Academy of General Dentistry's (AGD) 53rd Annual Meeting in Washington, D.C.

18 Jul 2005

High blood pressure reduces life expectancy

New research has found that the impact of high blood pressure on life expectancy may be far more significant than previously thought.

29 Jun 2005

Yet another proven benefit of tight glucose control for those with type 1 diabetes

New study results confirm, for the first time, that intensive treatment of diabetic patients results in a significantly lower risk of heart disease. In fact, it can cut the risk of cardiovascular disease nearly in half.

16 Jun 2005

GenoMed to be awarded new patent, for treating acute kidney failure without dialysis

GenoMed announced today that the US Patent Office has allowed claims and will be following up with an issued patent shortly on the Company's protocol to treat acute kidney failure with a drug rather than the dialysis machine.

14 Jun 2005

Fewer diabetics end up in hospital

According to new research from the U.S. Centers for Disease Control and Prevention (CDC), Americans with diabetes are less likely than they were a decade ago, to need hospitalization for serious complications such as kidney failure.

14 Jun 2005

Tight glucose control lowers CVD by about 50 percent in diabetes

A significantly lower risk of heart disease can now be added to the list of proven long-term benefits of tight glucose control in people with type 1 diabetes.

12 Jun 2005

Ruboxistaurin shows favorable effects on kidney damage and function in people with type 2 diabetes and nephropathy

Eli Lilly and Company today announced encouraging results from a one-year pilot study examining the effect of ruboxistaurin mesylate in persons with type 2 diabetes and kidney disease (also known as "diabetic nephropathy").

12 Jun 2005

Link between PKC enzyme and kidney disease in diabetes confirmed

Researchers at Joslin Diabetes Center have investigated PKC-beta - a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes - for more than two decades.

12 Jun 2005

Link between hyperglycemia (high blood glucose), overexpression of PKC-beta 2 and kidney disease

Scientists at Joslin Diabetes Center have investigated PKC-beta -- a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes -- for more than two decades.

10 Jun 2005

Rheumatoid arthritis costs more to business and industry than almost any other disease

Speaking at a rheumatology congress in Vienna today (Thursday 9 June), USA experts estimated that RA costs employers over $4,000 more per person, per year.

9 Jun 2005

Three pancreatic islet cell transplants successfully treat type 1 diabetic woman

A Davidson woman has been successfully treated for her Type 1 diabetes through a procedure performed at Carolinas Medical Center. Paul F. Gores, M.D., has led a multi-disciplinary team through a series of three pancreatic islet cell transplants since the summer of 2003. The result is a patient who is now insulin-free.

8 Jun 2005

La Jolla Pharmaceutical provides update on Riquent

La Jolla Pharmaceutical Company today announced that it has received "fast track" designation for Riquent (abetimus sodium) for the treatment of lupus renal disease from the U.S. Food and Drug Administration (FDA).

31 May 2005

Most serious side effects in statins may be higher in one of the newest drugs, rosuvastatin (Crestor)

A post-market analysis of cholesterol-lowering drugs called statins indicates that some of the most serious side effects may be higher in one of the newest drugs, rosuvastatin (Crestor). The drug is the strongest statin available because it has the greatest effect per milligram on low-density lipoprotein ("bad" cholesterol).

26 May 2005

New cholesterol drug Crestor causes safety concerns

A study by a leading medical journal has concluded that AstraZeneca's controversial drug Crestor produces more than twice as many side effects as other common cholesterol lowering treatments.

24 May 2005

Two out of three Americans with type-2 diabetes do not have their disease under control

According to a new survey two out of three Americans with type-2 diabetes do not have their disease under control and are putting themselves at risk of early deaths from stroke, heart attack or kidney failure as well as blindness and limb loss.

18 May 2005

Research proves the dangers of salt

Sydney University scientists have proved that salt has a dangerous adrenalin-inducing effect on people suffering from high blood pressure, or 'hypertension'.

10 May 2005

Chronic kidney disease linked to a single gene mutation

New research in the US has found that a mutation in a single gene causes a form of chronic kidney disease.

5 May 2005

Pharmacogenomics used to treat inherited kidney disorder of children

Mayo Clinic researchers have used pharmacogenomics to develop a test and treatment for an inherited kidney disorder that can cause organ failure in children and young adults.

4 May 2005

Obesity sends Type 2 diabetes rates in children soaring

Research results revealed at the Diabetes UK Annual Professional Conference, show 22 children under 16 have Type 2 diabetes in East London alone. Past estimates suggest there were only around 100 children diagnosed with Type 2 diabetes in the UK but this figure now appears to be a vast underestimate.

23 Apr 2005

Body's 24-hour internal clock linked to obesity and diabetes

Obesity and diabetes in both adults and children are rising at alarming rates and a wide range of culprits -- super-sized food portions, lack of exercise due to television, computers, suburban sprawl and loss of gym classes, high-fat and fast foods, sugar-laden drinks and psychological trauma -- have been blamed.

21 Apr 2005

Kidney Failure News and Research

New treatment option for bad breath

High blood pressure reduces life expectancy

Yet another proven benefit of tight glucose control for those with type 1 diabetes

GenoMed to be awarded new patent, for treating acute kidney failure without dialysis

Fewer diabetics end up in hospital

Tight glucose control lowers CVD by about 50 percent in diabetes

Ruboxistaurin shows favorable effects on kidney damage and function in people with type 2 diabetes and nephropathy

Link between PKC enzyme and kidney disease in diabetes confirmed

Link between hyperglycemia (high blood glucose), overexpression of PKC-beta 2 and kidney disease

Rheumatoid arthritis costs more to business and industry than almost any other disease

Three pancreatic islet cell transplants successfully treat type 1 diabetic woman

La Jolla Pharmaceutical provides update on Riquent

Most serious side effects in statins may be higher in one of the newest drugs, rosuvastatin (Crestor)

New cholesterol drug Crestor causes safety concerns

Two out of three Americans with type-2 diabetes do not have their disease under control

Research proves the dangers of salt

Chronic kidney disease linked to a single gene mutation

Pharmacogenomics used to treat inherited kidney disorder of children

Obesity sends Type 2 diabetes rates in children soaring

Body's 24-hour internal clock linked to obesity and diabetes

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News